Leigh Baldwin & Co’s Organon & Co OGN Stock Holding History

Leigh Baldwin & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,496	Closed	-$186K	–	188
2025 Q1	$186K	Sell	12,496 -3,250	-21%	-$50K	0.15%	162
2024 Q4	$235K	Buy	+15,746	New	+$257K	0.2%	148

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Leigh Baldwin & Co's OGN Position: Q2 2025 in Review

Leigh Baldwin & Co sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 12,496 shares — an estimated $186K sold.

Leigh Baldwin & Co first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $235K in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Leigh Baldwin & Co reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Leigh Baldwin & Co sold 12,496 Organon & Co shares in Q2 2025, an estimated $186K.
Leigh Baldwin & Co first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
Leigh Baldwin & Co's Organon & Co position peaked at $235K in Q4 2024.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Leigh Baldwin & Co's 13F filing for Q2 2025, filed 12 Aug 2025.